the use of nanoparticles to treat acute traumatic spinal cord injuries
Bibliographic record
Abstract
Spinal cord injuries (SCIs) are difficult to treat without using invasive methods that are not always precise or efficient. Traditional methods used to treat SCIs often involve targeting a broad area that is in close proximity to the specific locality of the injury as opposed to, direct targeting. Recent studies suggest the use of nanoparticles are a viable way to treat SCIs. Nanoparticles are nanotechnological devices that operate at 1x 10-9m, which is equivalent to one nanometer (nm). Nanoparticles target an assigned area with a high degree of specificity, thus ensuring that the affected area is treated with maximum proficiency. This article will explore the properties of silica nanoparticles, polymer nanoparticles and chondroitinase ABC (chABC) releasing nanoparticles to determine if they are appropriate to treat acute traumatic spinal cord injuries (tSCIs). A review of the literature suggests that the use of silica nanoparticles is a more plausible way to treat SCIs in comparison to polymer nanoparticles due to its zero-order drug release property. The application of silica nanoparticles ensures that the drug is released in the affected area in order to degrade damaged nerve tissue. In addition, chABC releasing nanoparticles show promising results in treating SCIs due to their ability to remove GAGs and promote nerve regeneration potentially, decreasing the healing time of an SCI. Overall, the application of nanoparticles provides a plausible non-invasive treatment method for SCIs. However, further research needs to be done in order to propagate the potential treatment applications of nanoparticles and human SCIs.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.000 | 0.000 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.000 |
| Bibliometrics | 0.001 | 0.000 |
| Science and technology studies | 0.000 | 0.000 |
| Scholarly communication | 0.001 | 0.001 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.001 | 0.001 |
| Insufficient payload (model declined to judge) | 0.001 | 0.001 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".